SoCalBio Mast
SoCalBio Weekly Update
Thanks to Lead SoCalBio Sponsors
 
 
  
SoCalBio Member Profile
 
WEST RIDGE ASSOCIATES, LLC  
WEST RIDGE ASSOCIATES, LLC provides merger and acquisition, corporate finance and related investment banking services to established middle market businesses, earlier stage companies with high growth potential, and commercialization stage companies in the biomed industry. West Ridge is represented on the SoCalBio Board of Directors by its Sr. Managing Director Chuck Troe (photo above). Visit Web Site
Take Advantage of SoCalBio's Group Purchasing Program to Cut the Cost of Doing Business
 
 
Vendor Showcase
 
For lab instruments and supplies
Looking for Help Finding Talent?
 
Recommended Events
 
 
 
-------------------------------------

Register Now
Join SoCalBio
 
Join well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth.
Become a Member
Past Weekly Updates
Editor: Ahmed A. Enany
President & CEO
Southern California Biomedical 
Council (SoCalBio)

September 28, 2009

Bookmark and Share

Upcoming Business Mixers

  • September 30, 4:00 - 7:00 pm
    • SoCalBio Networking Forum in Ventura County (Westlake Village Inn)

Focus: Innovation and Protecting Your Intellectual Property in a Changing Patent Regime ... More Info

  • October 29, 4:00 - 7:00 pm
    • SoCalBio Networking Forum in Los Angeles

Focus: Why Bioscience Companies Should Care About Social Media ... More Info

Social Media and the Biosciences
Do Drugs And Tweets Mix?
 
The drug biz is abuzz over social media. It's the new frontier. For a lot of PR and corporate communications teams it's all about new media and social media. Some biopharmas, big and small, now have directors of social media. Most are still trying to find their way, but the Food and Drug Administration may soon direct them... Read more
Expansion
Seal Beach Is Set to Play a Big Role in What Could Be a $1 Billion Drug to Fight Prostate Cancer
 
Seattle-based biotechnology drug developer Dendreon Corp. plans to open a plant in Seal Beach (photo right) that's set to produce Provenge, its prostate cancer vaccine. Dendreon plans to open the Seal Beach plant in the second half of 2011. In November, Dendreon is expected to submit an application for Provenge to the Food and Drug Administration ... Read more
Recent Financing Deals
 

Gamma Medica-Ideas Raises $24 Million in its First Round of Institutional Funding.

The Northridge-based developer of digital molecular imaging systems raised the money from Psilos Group, which led the $14 million equity tranche, and was joined by Capital Resource Partners (which also provided $5m in mezzanine debt). Bridge Banm provided a $5 million revolving line of credit. For more information see company's web site at: www.gm-ideas.com 
 
ValenTx Inc. Raises $22 Million in Series B Funding
 
The Carpinteria-based developer of minimally-invasive treatments for morbid obesity, has raised its round B from SV Life Sciences, which led the round and was joined by Covidien Ventures and return backers EDF Ventures, Affinity Capital Management, Kaiser Permanente Ventures, TGap Ventures and Sapient Capital Management. peHUB had previously reported on the round, based on a regulatory filing... Read more
Clinical Studies
Reverse Medical Corporation Receives FDA IDE Clinical Study Approval for the ReStore Microcatheter
 
Reverse Medical announced that it had received FDA conditional approval to begin a neurothrombectomy IDE study for its ReStore Microcatheter at twenty US centers. The study is planned to begin enrollment in US and European hospitals following investigating study center Institutional Review Board (IRB) approvals... Read more
Marketing
Biolase of Irvine Announces  Distribution Agreements in China
These distribution agreements followed the Company's August 12, 2009, announcement that it had received regulatory approval to market its Waterlase MD products in China ..... Read more
Jobs

For more jobs, sign up to access SoCalBio's LinkedIn Page

About SoCalBio

SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio